Media

News

Cannabinoids and the Treatment of Fibromyalgia

Cannabinoids offer a new frontier in the treatment of this debilitating disease.

Read more

Exploring the Untapped Potential: European Venture Funds in Niche Investment Areas

Sector specific funds outperform generalist contemporaries in key metrics according to published data.

Read more

Germany reveals new cannabinoid legislation

Germany's diminished recreational framework is a positive for the therapeutic sector.

Read more

Next generation drug discovery & ECS therapies

Synthetic biology is revolutionising the development of highly specific drugs, including those that target the endocannabinoid system.

Read more

What’s driving growth in the endocannabinoid therapeutics sector?

A range of factors are coming together to the sector's benefit.

Read more

Significant Exits in the Global MedCan Market

A number of multi billion dollar exits in the sector show the viability and potential of early stage medicinal cannabis…

Read more

A brilliant start to 2023 for the UK’s cannabinoid sector

January 2023 has been a month of positives for the UK medicinal cannabis sector.

Read more

Óskare’s 2022 market predictions come to fruition

Óskare Capital correctly called a range of key sector events in 2022.

Read more

January 2023 Newsletter

Our January 2023 update

Read more

Family Offices Boost Private Equity Investment For 2023

North American family offices are increasing private equity portfolio allocation in 2023.

Read more

How Medical Cannabis is Revolutionising Chronic Pain Management

Medical cannabis is providing doctors with a range of new treatments for chronic pain conditions.

Read more

Germany’s plan for legalisation flips its current supply model

Germany’s plan for legalisation changes its current supply model

Read more

Stopping new investments? Think again…

Fund allocations in a bear market

Read more

Medical Cannabis in the UK

Europe's fastest growing medical cannabis market

Read more

PODCAST: The UK Cannabis Investment Landscape

Canverse and Oskare Capital discuss the UK Cannabis Investment Landscape

Read more

Medical Cannabis Technology

For real upside, look beyond the plant

Read more

A Better Way to Invest in Cannabis

Private Market Placements vs Stock Market Investing

Read more

Medical Cannabis EIS and SEIS Fund Launched

The MEDCAN Fund has launched today

Read more

Óskare Capital’s First Portfolio Company, Octarine Bio, Raises $3 Million USD

April 2021

Read more

ÓSKARE CAPITAL QUARTERLY NEWSLETTER

APRIL 2021

Read more

Guest Post: The Symbiosis of Regulation and Science – Óskare Capital SAS

ÓSKARE Fund I & Medical Cannabinoids

Read more

ÓSKARE CAPITAL STRENGTHENS TEAM WITH TWO NEW MEMBERS

Óskare Capital is pleased to announce that Oliver Lamb will be joining as Co-Founder and Investment Manager in the investment…

Read more

The Medical Cannabis Opportunity in the EU Stimulus Package

The good news for Europe’s Medical Cannabis industry is that, although not specifically named, the sector has touch points in…

Read more

Broughton bids farewell to Mercia

Mercia Asset Management has lost its investment director and university lead Nicola Broughton to a new $171m fund targeting the…

Read more

Central Bank signs off on €150m legal cannabis fund

THE Central Bank of Ireland has given the green light for an Irish domiciled investment fund that is seeking to…

Read more

Medical cannabis private equity fund established

Ireland's first ever private equity medical cannabis fund has been established. The new venture has been set up by Crossroads…

Read more

Cannabis thérapeutique : un fonds veut doper l’écosystème européen

Oskare Capital lance Oskare Fund I, un fonds d'investissement qui va cibler des sociétés européennes développant des thérapies à base…

Read more

Octarine receives funding to develop biosynthetic platform for cannabinoid and psilocybin derivatives

Octarine Bio IVS (“Octarine” or the “Company”), a synthetic biology company developing functionally superior cannabinoid and psilocybin derivatives using microbial…

Read more